Kunyong Yang

Federal Circuit Finds Deuterated Analogs Of Small Molecule Drug Obvious

Product-By-Process Claims Invalid When The Process Does Not Impart Structural Or Functional Differences

PTAB Institutes Separate IPR Proceedings Filed By Codefendants, Finding That The Later IPR Proceeding Was Not Barred By 35 U.S.C. § 325(d), PTAB Litigation Blog